Sectra gets FDA nod for cardiac PACS

Swedish PACS provider Sectra has received Food and Drug Administration clearance for its cardiovascular imaging analysis package.

The application features functions for quantifying arterial stenosis and overall heart function, including tools for quantitative coronary analysis (QCA) and left ventricle analysis (LVA), according to the Linkoping-based vendor.

By AuntMinnie.com staff writers
May 7, 2004

Related Reading

Sectra buys Mamea, April 30, 2004

Sectra pursues new financing, April 7, 2004

Sectra signs Karolinska, March 19, 2004

Viatronix, Sectra to show off integration, March 4, 2004

Sectra Q3 profits rise, March 2, 2004

Copyright © 2004 AuntMinnie.com

Page 1 of 775
Next Page